New treatments for juvenile idiopathic arthritis

Isr Med Assoc J. 2002 Jan;4(1):39-43.

Authors

Philip J Hashkes¹, Orit Friedland, Yosef Uziel

Affiliation

¹ Department of Pediatrics and Pediatric Rheumatology Clinics, Rebecca Sieff Hospital, Safed, Israel.

PMID: 11802310

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antirheumatic Agents / therapeutic use
Arthritis, Juvenile / drug therapy*
Arthritis, Juvenile / surgery*
Child
Etanercept
Hematopoietic Stem Cell Transplantation*
Humans
Immunoglobulin G / therapeutic use
Infliximab
Receptors, Tumor Necrosis Factor / therapeutic use
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / therapeutic use*

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Immunoglobulin G
Receptors, Tumor Necrosis Factor
Tumor Necrosis Factor-alpha
Infliximab
Etanercept